SIGA Technologies
SIGA
#8737
Rank
โ‚น22.37 B
Marketcap
โ‚น311.93
Share price
0.62%
Change (1 day)
-46.24%
Change (1 year)

Revenue for SIGA Technologies (SIGA)

Revenue in 2026 (TTM): โ‚น8.11 Billion

According to SIGA Technologies's latest financial reports the company's current revenue (TTM ) is โ‚น8.94 Billion. In 2025 the company made a revenue of โ‚น8.48 Billion a decrease over the revenue in the year 2024 that were of โ‚น11.90 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for SIGA Technologies from 1997 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น8.11 B-4.47%
2025 โ‚น8.48 B-28.66%
2024 โ‚น11.90 B2.17%
2023 โ‚น11.64 B27.07%
2022 โ‚น9.16 B-7.87%
2021 โ‚น9.94 B8.87%
2020 โ‚น9.13 B379.22%
2019 โ‚น1.90 B-94.28%
2018 โ‚น33.35 B4158.04%
2017 โ‚น0.78 B-23.08%
2016 โ‚น1.01 B87.45%
2015 โ‚น0.54 B173.03%
2014 โ‚น0.19 B-41.64%
2013 โ‚น0.34 B-30.58%
2012 โ‚น0.49 B-27.04%
2011 โ‚น0.67 B-21.82%
2010 โ‚น0.86 B34.36%
2009 โ‚น0.64 B65.31%
2008 โ‚น0.38 B47.47%
2007 โ‚น0.26 B-18.21%
2006 โ‚น0.32 B-15.73%
2005 โ‚น0.38 B378.9%
2004 โ‚น79.65 M139.08%
2003 โ‚น33.31 M
2001 โ‚น55.94 M148.13%
2000 โ‚น22.54 M22.04%
1999 โ‚น18.47 M-13.1%
1998 โ‚น21.26 M-39.89%
1997 โ‚น35.36 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Sarepta Therapeutics
SRPT
โ‚น208.34 B 2,229.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น56.88 B 535.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น82.6 M-99.08%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น84.48 B 844.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น61.60 B 588.66%๐Ÿ‡บ๐Ÿ‡ธ USA